HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People On The Move: Appointments At Norgine, Lonza, Sabinsa

Executive Summary

A round-up of the latest appointments in Europe's health and wellness markets: Norgine names former L'Oreal exec as COO; Lonza appoints chairman to interim-CEO role; and Sabinsa hires head for new French office.

You may also be interested in...



People On The Move: Appointments At Weleda, Reckitt, FSA

A round-up of the latest appointments in Europe's health and wellness industry: Germany's Weleda names Tina Müller as its chief executive; Reckitt announces date when CEO-designate Kris Licht will take up full leadership of the company; the UK's Food Standards Agency appoints Welsh Food Advisory Committee chair.

People On The Move: Appointments At ANEFP, CHPA, Norgine, InfectoPharm, DSM

A round-up of the latest appointments in Europe's and the US health and wellness industries: Spain's ANEFP elects Martín as president;  US CHPA appoints Parks as senior VP of regulatory and scientific affairs, Norgine hires HRA's Hilton to lead its consumer business; Infectopharm names Weleda's Ammendola as R&D head; and DSM-Firmenich makes management changes.

Nestlé Partner Valbiotis Hails Trial Results For Prediabetes Supplement

Valbiotis and Nestlé Health Science plan to launch in 2024 a dietary supplement targeted at sufferers of prediabetes and type-2 diabetes following positive results from a recent study which showed the product's efficacy on key markers of glucose metabolism.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS154022

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel